Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by German Breast Group.
Recruitment status was  Active, not recruiting
Celgene Corporation
Roche Pharma AG
Information provided by (Responsible Party):
German Breast Group Identifier:
First received: April 18, 2012
Last updated: February 10, 2014
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)